Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4601
Children's Place
PLCE
$54.3M
| $25.6K | ﹤0.01% |
2,927
-921
| -24% | -$8.57K |
|
4602
CALL
Chegg
CHGG
$110M
| $25.6K | ﹤0.01% |
40,000
| – | – |
|
4603
Schwab U.S Small- Cap ETF
SCHA
$22.2B
| $25.1K | ﹤0.01% |
1,072
| – | – |
|
|
NBP
4604
NovaBridge Biosciences American Depositary Shares
NBP
$185M
| $25K | ﹤0.01% |
30,370
| – | – |
|
4605
Innovator US Equity Buffer ETF February
BFEB
$254M
| $25K | ﹤0.01% |
602
+502
| +502% | +$21.5K |
|
4606
TMC The Metals Company
TMC
$1.54B
| $24.9K | ﹤0.01% |
14,492
| – | – |
|
4607
America Movil
AMX
$76.1B
| $24.9K | ﹤0.01% |
1,748
-20,840
| -92% | -$299K |
|
|
GBIO
4608
DELISTED
Generation Bio
GBIO
| $24.8K | ﹤0.01% |
6,115
-2,475
| -29% | -$17.4K |
|
4609
Takeda Pharmaceutical
TAK
$54.6B
| $24.6K | ﹤0.01% |
1,654
+709
| +75% | +$9.93K |
|
4610
Mitsubishi UFJ Financial
MUFG
$253B
| $24.5K | ﹤0.01% |
1,797
-18,390
| -91% | -$237K |
|
4611
Diageo
DEO
$49B
| $24.4K | ﹤0.01% |
233
-2,366
| -91% | -$267K |
|
|
ZSPC
4612
DELISTED
ZSPACE INC NEW
ZSPC
| $24.3K | ﹤0.01% |
+131
| New | +$44.6K |
|
4613
374Water
SCWO
$38.1M
| $24.2K | ﹤0.01% |
7,129
-3,230
| -31% | -$14.3K |
|
4614
McEwen Inc
MUX
$1.03B
| $24.1K | ﹤0.01% |
+3,188
| New | +$24.9K |
|
4615
Prairie Operating Co
PROP
$69.8M
| $24K | ﹤0.01% |
4,489
-2,127
| -32% | -$15.5K |
|
|
MBAVU
4616
DELISTED
M3-Brigade Acquisition V Corp Units
MBAVU
| $23.9K | ﹤0.01% |
2,310
-37
| -2% | -$379 |
|
4617
Harvard Bioscience
HBIO
$27.5M
| $23.6K | ﹤0.01% |
4,176
-2,040
| -33% | -$26.1K |
|
4618
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$429M
| $23.4K | ﹤0.01% |
300
| – | – |
|
|
AUTL
4619
Autolus Therapeutics
AUTL
$397M
| $23.4K | ﹤0.01% |
15,068
+3,209
| +27% | +$6.51K |
|
4620
AllianzIM U.S. Equity Buffer20 May ETF
MAYW
$448M
| $23.2K | ﹤0.01% |
+757
| New | +$23.3K |
|
4621
Motorcar Parts of America
MPAA
$254M
| $23K | ﹤0.01% |
2,422
-1,592
| -40% | -$13.9K |
|
|
VIGL
4622
DELISTED
Vigil Neuroscience
VIGL
| $22.6K | ﹤0.01% |
12,688
-51,361
| -80% | -$115K |
|
4623
Century Therapeutics
IPSC
$364M
| $22.5K | ﹤0.01% |
47,209
-23,266
| -33% | -$17.5K |
|
4624
Euroseas
ESEA
$557M
| $22.2K | ﹤0.01% |
725
-166
| -19% | -$4.62K |
|
|
CMBT
4625
CMB.TECH NV
CMBT
$4.69B
| $22.2K | ﹤0.01% |
2,443
+1,502
| +160% | +$15.2K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.